Dashboard
Manage Tickers

RADX Radiopharm Theranostics Ltd


$ 4.52 $ 0.11 (2.61 %)    

Monday, 17-Nov-2025 15:39:23 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 602.34 $ -5.20 (-0.85 %)
DIA $ 466.18 $ -5.48 (-1.16 %)
SPY $ 664.83 $ -6.26 (-0.93 %)
TLT $ 89.11 $ 0.22 (0.25 %)
GLD $ 370.86 $ -4.31 (-1.15 %)
$ 4.515
$ 4.50
$ 4.40 x 1,300
$ 4.67 x 200
$ 4.24 - $ 4.50
$ 3.50 - $ 50.82
17,553
na
na
$ 0.68
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Radiopharm Theranostics Announces Phase 2b...
11/17/2025 13:04:34

Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to M...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
11/13/2025 21:06:42

Core News & Articles
Radiopharm Theranostics Completes Enrollme...
11/12/2025 13:36:12

Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceut...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
10/27/2025 21:06:06

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
10/20/2025 21:08:49

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

Core News & Articles
Radiopharm Theranostics Announces Update O...
10/20/2025 12:03:07

Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from s...

Core News & Articles
Trading Halt: Halt status updated at 7:00:...
10/20/2025 11:00:05

Core News & Articles
Trading Halt: Halted at 7:01:04 a.m. ET - ...
10/15/2025 11:01:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 12:09:25

Core News & Articles
Radiopharm Theranostics Receives Recommend...
10/01/2025 12:12:33

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/15/2025 21:06:07

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 17:06:31

Core News & Articles
Radiopharm Theranostics Reported FY25 Cash...
07/29/2025 11:41:24

Financial updateThe following is a summary of the Appendix 4C Cash Flow Report:The year-end closing cash balance was $29.12 mil...

Core News & Articles
Radiopharm Theranostics Announces That The...
07/28/2025 12:10:39

- Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceu...

Core News & Articles
Radiopharm Gets Green Light to Test Tumor-...
07/28/2025 11:47:09

Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, &, ldquo, Radiopharm&, rdquo, or the &, ldquo, Company&, rdquo,...

Core News & Articles
Brookline Capital Initiates Coverage On Ra...
07/21/2025 12:33:57

Brookline Capital analyst Kemp Dolliver initiates coverage on Radiopharm Theranostics (NASDAQ:RADX) with a Buy rating and an...

Core News & Articles
Radiopharm Theranostics Signs Supply Agree...
06/24/2025 12:15:37

RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profileEthics approval and Phase 1...

Core News & Articles
Radiopharm Theranostics' RAD101 Receives F...
06/11/2025 12:10:31

Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company fo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION